Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant

NCT01280955 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Failure of Bone Marrow Graft

Interventions

DRUG: Plerixafor

Sponsor

Mitchell Horwitz, MD

Collaborators

[object Object]